Table of Contents
Table of Contents
Preface
Chapter 1 – Pharmaceutical Supply Chain Security (pp. 1-26)
Susan Thaul
Chapter 2 – Statement of Janet Woodcock, Director, Center for Drug Evaluation and Research, FDA. Hearing on ”Securing Our Nation’s Prescription Drug Supply Chain” (pp. 27-32)
Chapter 3 – Testimony of Elizabeth A. Gallenagh, Vice President, Government Affairs, Healthcare Distribution Management Association. Hearing on ”Securing Our Nation’s Prescription Drug Supply Chain” (pp. 33-36)
Chapter 4 – Testimony of Christine Simmon, Senior Vice President, Policy & Strategic Alliances, Generic Pharmaceutical Association. Hearing on ”Securing Our Nation’s Prescription Drug Supply Chain” (pp. 37-44)
Chapter 5 – Testimony of Michael Rose, Vice President, Supply Chain Visibility, Johnson and Johnson Health Care Systems, Inc. Hearing on ”Securing Our Nation’s Prescription Drug Supply Chain” (pp. 45-49)
Chapter 6 – Testimony of Tim Davis, Owner, Beaver Health Mart Pharmacy. Hearing on ”Securing Our Nation’s Prescription Drug Supply Chain” (pp. 49-52)
Chapter 7 – Testimony of Allan Coukell, Director, Medical Programs, The Pew Charitable Trusts. Hearing on ”Securing Our Nation’s Prescription Drug Supply Chain” (pp. 53-60)
Chapter 8 – Testimony of Carmen A. Catizone, Executive Director, National Association of Boards of Pharmacy. Hearing on ”Securing Our Nation’s Prescription Drug Supply Chain” (pp. 61-66)
Chapter 9 – Statement of Deborah M. Autor, Deputy Commissioner for Global Regulatory Operations and Policy, FDA. Hearing on ”Securing The Pharmaceutical Supply Chain” (pp. 67-76)
Chapter 10 – Drug Safety: FDA Faces Challenges Overseeing the Foreign Drug Manufacturing Supply Chain. Statement of Marcia Crosse, Director, Health Care, U.S. Government Accountability Office. Hearing on ”Securing the Pharmaceutical Supply Chain” (pp. 77-92)
Index